Skip to content

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05688488
Enrollment
100
Registered
2023-01-18
Start date
2023-05-05
Completion date
2026-12-31
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glottic Web of Larynx, Laryngeal Stenosis, Glottic Carcinoma, Laryngeal Leucoplakia, Laryngeal Polyp, Laryngeal Papilloma

Keywords

Curcumin

Brief summary

To provide a novel therapy idea and method to solve the clinical problem of postoperative adhesion of bilateral vocal cords, patients enrolled in this study will be applied with curcumin on both wound sites of bilateral vocal cords after the surgery on the bilateral vocal cord endoscopically.

Interventions

DRUGCurcumin

Curcumin was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.

Mitomycin-C was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.

Sponsors

Eye & ENT Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with bilateral vocal cord diseases who are going to undergo resection of bilateral vocal cord lesions endoscopically. 2. Patients with bilateral vocal cord adhesion who are going to undergo incision of bilateral vocal cord adhesion endoscopically.

Exclusion criteria

1. Patients with other laryngeal diseases. 2. Patients with cardiac and pulmonary insufficiency. 3. Patients unable to cooperate with the follow-up on time after surgery. 4. Patients who refuse to sign the informed consent after notification. 5. Patients who have a severe allergic disease or allergic history to a variety of drugs. 6. Other circumstances that are not appropriate to be included in the clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with laryngeal web formation as assessed by videolaryngoscope1 year postsurgeryAll participants received the videolaryngoscope every month post-surgery, and a laryngeal web is defined as a visible adhesion whose length reached 1 mm or greater.

Countries

China

Contacts

Primary ContactJian Chen, Ph.D
chenjent@qq.com+8621-64377134
Backup ContactHaitao Wu, Ph.D
eentwuhaitao@163.com+8621-64377134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026